Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-18-021027

COO, CSO bought 10,000 shares at $0.40 ($4,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cavanagh William COO, CSO 2018-11-16 Purchase +10,000 $0.40 $4,000 10,000 D: show line 1 in the form
Open-market purchases · 10,000 sh · avg $0.40 · $4,000
Loading xslF345X03/rdgdoc.xml…